Loading resource…

UpToDate, Inc.
The document outlines critical information regarding sacubitril and valsartan, a combination medication used primarily for heart failure management. It details the pharmacologic properties, dosing recommendations for adults, and important safety alerts, including potential risks during pregnancy. Additionally, it discusses the implications of switching from other heart failure medications and provides insights into drug interactions and monitoring requirements.
No account needed